ponedjeljak, 20. veljače 2017.

Amjevita Is the FDA-Approved Biosimilar to Humira

Verywell
Amjevita Is the FDA-Approved Biosimilar to Humira
Amjevita is the third biosimilar approved for rheumatoid arthritis and other inflammatory types of arthritis. There have been some concerns expressed regarding biosimilars.
READ NOW 
READ THESE NEXT
What Exactly Are Biosimilars? MORE
Inflectra Is the Biosimilar to Remicade MORE
Erelzi Is the Biosimilar to Enbrel MORE
Verywell
AN ABOUT.COM BRAND
You are receiving this newsletter because you subscribed to the Real Life with Arthritis newsletter.
If you wish to unsubscribe, please click here
1500 Broadway, 6th Floor, New York, NY, 10036
© 2017 Verywell.com - All rights reserved. Privacy Policy.
                                                           

Nema komentara:

Objavi komentar